Source link : https://www.newshealth.biz/health-news/do-patients-prefer-access-or-benefit/
When the US Food and Drug Administration (FDA) grants cancer drugs accelerated approval, a key aim is to provide patients faster access to therapies that can benefit them. The downside of a speedier approval timeline, however, is that it’s often not yet clear whether the new drugs will actually allow a patient to live longer […]
Author : News Health
Publish date : 2024-12-09 09:01:17
Copyright for syndicated content belongs to the linked Source.